HealthEquity, Inc. (HQY)

HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.

HealthEquity (HQY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

HQY stock gains post Q3 results as earnings and revenue top estimates, supported by rising HSAs and stronger margins.

HealthEquity, Inc. (HQY) Q3 2026 Earnings Call Transcript

The headline numbers for HealthEquity (HQY) give insight into how the company performed in the quarter ended October 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

HealthEquity (HQY) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.9 per share. This compares to earnings of $0.78 per share a year ago.

Highlights of the third quarter include: Revenue increased 7% to $322.2 million. Net income per diluted share rose to $0.59 from $0.06 one year ago, and non-GAAP net income per diluted share increased 29% to $1.01.

HealthEquity, Inc. remains an asset-light growth opportunity, with a $120/share price target supported by strong Q2 FY26 results. HQY's recurring, asset-linked revenues, 70%+ gross margins, and expanding HSA penetration drive robust returns and positive operating leverage. Management's disciplined capital allocation, improving cost structure, and new legislative tailwinds expand HQY's total addressable market and growth runway.

Advantage Alpha Capital Partners LP reduced its stake in shares of HealthEquity, Inc. (NASDAQ: HQY) by 27.8% during the undefined quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 44,714 shares of the company's stock after selling 17,202 shares during the period. HealthEquity makes up about 1.3%

Evaluate the expected performance of HealthEquity (HQY) for the quarter ended October 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

HQY rides on strong HSA growth, AI-driven efficiency gains and solid Q2 results, though data security threats remain a key risk.

Investors interested in stocks from the Medical Services sector have probably already heard of Progyny (PGNY) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors?

HQY's new agentic AI is likely to provide faster, more intuitive support across channels, aiming to boost member satisfaction.

DRAPER, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY), the nation's largest Health Savings Account (HSA) and consumer-directed benefits administrator, today announced a new development in building upon its technology investments to transform member experience. The company will deploy agentic AI capabilities that fundamentally change how members access support, working with leading customer experience (CX) agent builder Parloa to mark a significant evolution in leveraging intelligent, conversational AI that understands member needs and takes action in real time.